Cadence Minerals #KDNC – Amapá Operational Update, Placing to Raise £525,000 and Loan Note Restructuring
Cadence Minerals – Amapá Operational Update, Placing to Raise £525,000 and Loan Note Restructuring. Highlights Shipping of first iron ore is on target for late Q2 2020 / early Q3 2020 Shipment is planned via 45,000-tonne bulk carriers at a rate of 2 -3 every two months Independent surveys of these iron ore stockpiles indicate […]
Grand Vision Media Holdings #GVMH – Trading Statement
The directors of GVMH announce the following update. Unaudited revenue for the year ended 31 December 2019 has fallen short of the prior year, at HKD12,034K [2018 : HKD18,026K]. The decline in sales was predominantly as a result of reduced advertising revenues from the OOH cinema sector, and reduced digital marketing revenues. The social unrest […]
Open Orphan #ORPH: The Times – Inside Story of coronavirus battlers. The Sun – We salute the unsung key workers.
Inside stories of coronavirus battlers Aerogen, Hibergene, Open Orphan and Nearform Ireland was placed sixth last week in a list of nations ranked on their response to the Covid-19 crisis in terms of innovation. The league table was compiled by StartupBlink, a Swiss-Israeli company that collates data on start-ups; the United Nations-backed Health Innovation Index; […]
Irish Independent – Open Orphan subsidiary starts testing drug for treating Covid-19
by Ellie Donnelly A subsidiary of Open Orphan has started testing a drug that could potentially treat Covid-19. Open Orphan is a Europe- focused pharma services company specialising in rare disease and so-called orphan drugs. The tests are being carried out by its London-based subsidiary Hvivo on behalf of its client Nearmedic International. The drug […]
Tiziana Life Sciences #TILS – Issue of Equity and Resulting Total Voting Rights. Update on AIM cancellation and migration to Nasdaq.
London, New York, 24 April 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has allotted and issued a total of […]
Irish Times – Open Orphan to test Covid-19 drug through London subsidiary
Pharma company steps up fight against virus that has infected more than 2.6m worldwide by Ciara O’Brien Dublin-listed pharma services company Open Orphan has begun testing an anti-viral treatment for Covid-19 through its London-based subsidiary Hvivo. The testing is being carried out on behalf of Nearmedic International, a specialist pharmaceutical, biotechnological and medical company headquartered […]
Cadence Minerals #KDNC – European Metals #EMH – CEZ Investment into Cinovec Project Approved.
Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) is pleased to note the update today from European Metals Holdings Limited (“European Metals” “EMH” or “the Company”) that shareholders have today approved at the General Meeting of the Company, the amended arrangements for the investment of EUR 29.1 million (approximately GBP 25.8 million) by CEZ a.s. (“CEZ”) for […]
Open Orphan #ORPH – Testing of anti-viral for treating COVID-19 underway
Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that its London-based subsidiary hVIVO has commenced the testing of an anti-viral for treating COVID-19 on behalf of […]
Tiziana Life Sciences – Clinical pipeline update, resolutions seeking shareholder authority to issue new shares for cash & approval of proposed option grant
London, New York 21 April 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), the U.S. and U.K. biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today announces that it has convened a general meeting (the “GM”) […]
Catenae Innovation #CTEA – Conditional Placing to raise £320,000 and Update
Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, today announces that it has conditionally raised gross proceeds of £320,000 by placing 32,000,000 new ordinary shares (“Placing Shares”) at a price of 1p per share (the “Placing”). The holders of the Placing Shares will receive warrants to subscribe for a […]